Immutep Ltd
Company Profile
Business description
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives the majority of the revenue from the sale of the products.
Contact
264 George Street
Level 33, Australia Square
Sydney NSW 2000
AUST: +61 283157003
E: enquiries@immutep.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
41
Stocks News & Analysis
stocks
Four cheap wide moat ASX stocks
stocks
5 top US dividend shares from the best managers
stocks
Undervalued ASX company announces turnaround plan for lagging operations
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,862.30 | 147.10 | -1.84% |
| CAC 40 | 7,932.61 | 112.50 | -1.40% |
| DAX 40 | 17,766.23 | 260.35 | -1.44% |
| Dow JONES (US) | 37,798.97 | 63.86 | 0.17% |
| FTSE 100 | 7,820.36 | 145.17 | -1.82% |
| HKSE | 16,248.97 | 351.49 | -2.12% |
| NASDAQ | 15,865.25 | 19.77 | -0.12% |
| Nikkei 225 | 38,471.20 | 761.60 | -1.94% |
| NZX 50 Index | 11,792.36 | 12.48 | -0.11% |
| S&P 500 | 5,051.41 | 10.41 | -0.21% |
| S&P/ASX 200 | 7,612.50 | 140.00 | -1.81% |
| SSE Composite Index | 3,007.07 | 50.31 | -1.65% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| The Star Entertainment Group Ltd SGR | 0.42 | 0.07 | -14.43% |
| Sayona Mining Ltd SYA | 0.04 | 0.00 | -7.89% |
| Imugene Ltd IMU | 0.08 | 0.01 | -8.79% |
| Telstra Group Ltd TLS | 3.68 | 0.03 | -0.81% |
| Zip Co Ltd ZIP | 1.19 | 0.15 | -10.90% |
| Resolute Mining Ltd RSG | 0.43 | 0.06 | -12.24% |
| Peninsula Energy Ltd PEN | 0.10 | 0.01 | -6.67% |
| Pilbara Minerals Ltd PLS | 3.85 | 0.05 | -1.28% |
| Piedmont Lithium Inc PLL | 0.22 | 0.07 | -22.81% |
| Liontown Resources Ltd LTR | 1.18 | 0.08 | -6.35% |